Key result
Speckle-tracking echocardiography detects subclinical myocardial dysfunction to guide annual surveillance in bodybuilders.
Why the study?
Sudden cardiac death is a serious and preventable outcome in competitive bodybuilding, and athletes exposed to anabolic-androgenic steroids exhibit subclinical myocardial dysfunction with preserved ejection fraction that conventional echocardiography misses.
This paper synthesizes evidence on subclinical myocardial dysfunction in anabolic-androgenic steroid-using bodybuilders and proposes an ethical, scalable annual strain echocardiography surveillance protocol using a traffic-light risk system to reduce sudden cardiac death while preserving athlete autonomy.
Answers are grounded in this paper and cite their sources.
May support annual strain surveillance in AAS-exposed bodybuilders; leaves open prospective validation of SCD reduction.
Sudden cardiac death (SCD) has emerged as one of the most serious—and most preventable—outcomes in competitive bodybuilding, with an estimated incidence of 32.83 per 100,000 athlete-years among active competitors and a risk more than five times higher in professionals than in amateurs. Speckle-tracking (strain) imaging studies show that athletes exposed to anabolic-androgenic steroids (AAS) have reduced myocardial deformation (a less negative global longitudinal strain, or GLS), often with a preserved ejection fraction—a pattern of subclinical dysfunction that conventional echocardiography misses. This article has two complementary aims: (1) to synthesize the scientific evidence supporting strain echocardiography as a cardiovascular surveillance tool in this population; and (2) to present an operational proposal—a Structured Cardiovascular Surveillance Protocol (SCSP)—that turns this evidence into a practical, replicable routine, bringing federations, coaches, athletes, and partner cardiology services together around an annual screening schedule, without any of these parties taking on the role of deciding for the athlete. The protocol is built on ongoing education, partnerships between events and health care providers to expand access to testing, and a color-coded (traffic-light) risk classification system that communicates results clearly while protecting medical confidentiality and athlete autonomy. We argue that pairing robust clinical evidence with a simple, ethical, and scalable institutional design offers a concrete path toward reducing fatal cardiac events in the sport.
No takes yet. Share an insight, caveat, or question.
Marcos Paulo Nonato de Almeida (2026) conducted a review in Anabolic-androgenic steroid (AAS)-associated myocardial dysfunction and sudden cardiac death risk in competitive bodybuilding. Structured Cardiovascular Surveillance Protocol (SCSP) using speckle-tracking (strain) echocardiography was evaluated on Subclinical myocardial dysfunction (left ventricular global longitudinal strain [GLS]) and sudden cardiac death (SCD). Speckle-tracking echocardiography detects AAS-related subclinical dysfunction to guide an annual traffic-light surveillance protocol in bodybuilders.
Synapse has enriched 10 related papers. Consider them for comparative context: